Urinary Incontinence - Epidemiology Insights to 2025

Publisher Name :
Date: 05-Jul-2017
No. of pages: 40
Price : Single User: US $ 2950  US $ 2360 Corporate User: US $ 8850  US $ 5310
This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight " Urinary Incontinence - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Urinary Incontinence in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Urinary Incontinence prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Urinary Incontinence. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Scope of the Report

The Report includes the prevalent population and how will it change over the next eight years.

Prevalent or incident cases segmented by age and sex.

Coverage of key Urinary Incontinence subpopulations and its prevalent or incident cases

The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

The report will help in developing business strategies by understanding the trends shaping and driving the global Urinary Incontinence market.

Identifying prevalent patient populations as well as risk factors in the global Urinary Incontinence market will help to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the best opportunities for Urinary Incontinence therapeutics in each of the markets covered.

This report is available at 20% Discount for Single User License and 40% Discount for Corporate Users License till 31 December 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Urinary Incontinence - Epidemiology Insights to 2025

Table of Contents

Report Introduction
Snapshot of Total Prevalent or Incident cases by 7 MM
Executive Summary
Key Findings
Urinary Incontinence
Overview
Urinary Incontinence Definition
Pathophysiology
Symptoms
Etiology
Risk Factors Associated with Urinary Incontinence
Disease Burden & Unmet Need in the Market
Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Urinary Incontinence
Sex-Specific Prevalent/Incident Cases Urinary Incontinence
Disease Type Specific Prevalent/Incident Cases of Urinary Incontinence
Prevalent & Incident Cases by 7 MM-2015-2025
Urinary Incontinence Epidemiology of United States-2025
Urinary Incontinence Epidemiology of United Kingdom-2025
Urinary Incontinence Epidemiology of Germany-2025
Urinary Incontinence Epidemiology of France-2025
Urinary Incontinence Epidemiology of Spain-2025
Urinary Incontinence Epidemiology of Italy-2025
Urinary Incontinence Epidemiology of Japan-2025.
Key Takeaways
Appendix
Report Methodology
Consulting Services
Disclaimer
About Us

List of Tables

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Urinary Incontinence Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Urinary Incontinence (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Urinary Incontinence Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Urinary Incontinence (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Urinary Incontinence Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Urinary Incontinence Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Urinary Incontinence (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Urinary Incontinence Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Urinary Incontinence(Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Urinary Incontinence Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Urinary Incontinence Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Urinary Incontinence Sub-population, Japan (2015-2025)

List of Figures

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Urinary Incontinence Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Urinary Incontinence (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Urinary Incontinence Sub-population, US (2015-2025)
Figure 7: Prevalent Cases of Urinary Incontinence (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Urinary Incontinence Sub-population, United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Urinary Incontinence Sub-population, Germany (2015-2025)
Figure 13: Prevalent Cases of Urinary Incontinence (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Urinary Incontinence Sub-population, France (2015-2025)
Figure 16: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Urinary Incontinence Sub-population, Italy (2015-2025)
Figure 19: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Urinary Incontinence Sub-population, Spain (2015-2025)
Figure 22: Prevalent Cases of Urinary Incontinence (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Urinary Incontinence By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Urinary Incontinence Sub-population, Japan (2015-2025)

  • Global Overactive Bladder Treatment Market Research Report 2017
    Published: 09-Nov-2017        Price: US 2900 Onwards        Pages: 115
    This report studies Overactive Bladder Treatment in Global market, especially in North America, Europe, China, Japan, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering Astellas Pharma Allergan Pfizer Teva (Activas) Johnson & Johnson Market Segment by Regions, this report splits Global into several key Regions, with consumption, revenue, market share and growth rate of Overactive Bladder T......
  • Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Cystitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Cystitis which can turn out to be future prospe......
  • Nocturnal Enuresis -Epidemiology Forecast to 2025
    Published: 01-Nov-2017        Price: US 2750 Onwards        Pages: 40
    DelveInsight "Nocturnal Enuresis - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Nocturnal Enuresis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Nocturnal Enuresis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with......
  • Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM
    Published: 01-Nov-2017        Price: US 4950 Onwards        Pages: 77
    DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage ......
  • Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Interstitial Cystitis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Interstitial Cystitis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Interstitial Cystitis......
  • Nocturnal Enuresis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Nocturnal Enuresis - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Nocturnal Enuresis - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patter......
  • Bladder Pain - Pipeline Insight, 2017
    Published: 01-Nov-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, " Bladder Pain -Pipeline Insights, 2017", report provides comprehensive insights about pipeline drugs across this Bladder Pain. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Bladder Pain. This report provides information on the therapeutic development for Bladder Pain, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, pre-clinical as well as disco......
  • Cystitis - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Cystitis - Market Insights, Epidemiology and Market Forecast - 2025" Reports provides an overview of the disease and global market size of the Cystitis for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Cystitis forecasted market share for ten years to 2025 segmented by seven major markets. In addition, the report includes the historical and forecasted epidemiologica......
  • Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Urinary Incontinence - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Urinary Incontinence. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Urinary Incontinence wh......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs